News

Home / News

Announcement on behalf of major subsidiary, CHUANG YI BIOTECH CO., LTD.,of executive personnel change

Announcement on behalf of major subsidiary, CHUANG YI BIOTECH CO., LTD.,of executive personnel change

2025.3.24

...

More

TSH Biopharm was invited to attend the institutional investor conference hosted by Reliance Securities

TSH Biopharm was invited to attend the institutional investor conference hosted by Reliance Securities

2025.3.13

...

More

TSH Board of Directors resolved to convene the 2025 Annual General Shareholders' Meeting

TSH Board of Directors resolved to convene the 2025 Annual General Shareholders' Meeting

2025.2.21

...

More

TSH Board of Directors Resolution on Distribution of 2024 Earnings

TSH Board of Directors Resolution on Distribution of 2024 Earnings

2025.2.21

...

More

TSH Board of Directors Approved the Consolidated Financial Statements For the Year Ended December 31, 2024

TSH Board of Directors Approved the Consolidated Financial Statements For the Year Ended December 31, 2024

2025.2.21

...

More

Announcement on behalf of major subsidiary, CHUANG YI BIOTECH CO., LTD.,regarding BOD's resolution to distribute cash dividends

Announcement on behalf of major subsidiary, CHUANG YI BIOTECH CO., LTD.,regarding BOD's resolution to distribute cash dividends

2025.2.20

...

More